Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the Company) announced that at the 2025 European Society for Medical ...